Chronic hepatitis B (HBV) and delta (HDV) infections remain major global health challenges. Nucleos(t)ide analogues (NUCs) and bulevirtide, a recently approved entry inhibitor, effectively suppress HBV and HDV replication, respectively, thereby reducing the risk of liver-related complications. However, they rarely indu...
A. Pocurull, S. Battistella, Xavier Forns et al.· Annals of Hepatology· 0 citations
INTRODUCTION
Non-invasive tests (NITs) accurately detect fibrosis and may reduce the need for liver biopsy (LB). Detection of advanced fibrosis (≥F3) is clinically important for prognosis, but few studies have explored the use of NITs in patients with Wilson Disease (WD).
METHODS
In this multicentre observational stu...
Frederik Teicher Lauridsen Kirk, Zoe Mariño, U. To et al.· Clinical and Translational G...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.